Stock chart
Analyses on Grace Breeding (4)
- March 24, 2026March 24, 2026
- Follow-up
Grace Breeding: if Maoz succeeds, how much of the value really reaches the listed company
Even if Maoz reaches commercialization, Grace Breeding shareholders do not own 100% of the value platform: the activity and IP sit in Grace Technologies, where the listed company owns 85%, while Indofil still retains corporate rights despite not funding its share since 2021.
G - Follow-up
Grace Breeding: what is left of the Brazil route after Sinova
After Sinova, Grace’s Brazil route remained alive but moved one step back: the agronomic proof behind Maoz got stronger while the distribution and launch path weakened. GAPES gives the company a more credible professional route, but even the January 2026 agreement still places 2…
G - Follow-up
Grace Breeding: how much time is really left before commercialization proof
Better field validation and tighter costs extended the runway, but Grace Breeding is still measuring the path to commercialization proof in months rather than in multiple quarters because cash remains thin and the company is still dependent on short financing rounds and compensa…
G Grace Breeding 2025: Maoz now has field proof, but the company still has not proved commercialization
Grace Breeding ended 2025 with real improvement in Maoz Bio 5 field proof, but without commercial proof. The product moved forward, Brazil produced stronger data and a GAPES recommendation, yet the company itself remained without revenue, without backlog, with a tiny cash box an…
G
